pubmed-article:15509159 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15509159 | lifeskim:mentions | umls-concept:C0034804 | lld:lifeskim |
pubmed-article:15509159 | lifeskim:mentions | umls-concept:C0752229 | lld:lifeskim |
pubmed-article:15509159 | lifeskim:mentions | umls-concept:C1521991 | lld:lifeskim |
pubmed-article:15509159 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:15509159 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:15509159 | pubmed:issue | 23 | lld:pubmed |
pubmed-article:15509159 | pubmed:dateCreated | 2004-10-28 | lld:pubmed |
pubmed-article:15509159 | pubmed:abstractText | We present and examine the efficacy of a novel benzoxepin-based scaffold for modulation of the human estrogen receptor. Receptor tolerance of this new molecular scaffold is examined through presentation of experimentally determined antiproliferative effects on human MCF-7 breast tumor cells and measured binding affinities. The effect of functional group substitution on the benzoxepin scaffold is explored through a brief computational structure-activity relationship investigation with molecular simulation. | lld:pubmed |
pubmed-article:15509159 | pubmed:language | eng | lld:pubmed |
pubmed-article:15509159 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15509159 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15509159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15509159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15509159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15509159 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15509159 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15509159 | pubmed:month | Nov | lld:pubmed |
pubmed-article:15509159 | pubmed:issn | 0022-2623 | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:LloydDavid... | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:CampianiGiuse... | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:FattorussoCat... | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:CatalanottiBr... | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:ZistererDanie... | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:WilliamsD... | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:HughesRosario... | lld:pubmed |
pubmed-article:15509159 | pubmed:author | pubmed-author:MeeganMary... | lld:pubmed |
pubmed-article:15509159 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15509159 | pubmed:day | 4 | lld:pubmed |
pubmed-article:15509159 | pubmed:volume | 47 | lld:pubmed |
pubmed-article:15509159 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15509159 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15509159 | pubmed:pagination | 5612-5 | lld:pubmed |
pubmed-article:15509159 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:meshHeading | pubmed-meshheading:15509159... | lld:pubmed |
pubmed-article:15509159 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15509159 | pubmed:articleTitle | Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor. | lld:pubmed |
pubmed-article:15509159 | pubmed:affiliation | Department of Biochemistry, Trinity College Dublin, Dublin 2, Ireland. | lld:pubmed |
pubmed-article:15509159 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15509159 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:15509159 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15509159 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15509159 | lld:pubmed |